3513659621

154

Cupi, M. L., M. Sarra, D. De Nitto, E. Franze, I. Marafini, I. Monteleone, G. Del Vecchio Blanco, O. A. Paoluzi, D. Di Fusco, P. Gentileschi et al. (2014). Defective expression of scavenger receptors in celiac disease mucosa. PLoS One, 9, e 100980.

Dammerman, M. et J. L. Breslow (1995). Genetic basis of lipoprotein disorders. Circulation, 91, 505-512.

Daviet, L. et J. L. McGregor (1997). Le CD36, un rćcepteur multifonctionnel. Hematologie, 3, 132-137.

Dawson, D. W., S. F. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier et N. P. Bouck (1997). CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Celi Biol, 138, 707-717.

Day, T. F., X. Guo, L. Garrett-Beal et Y. Yang (2005). Wnt/beta-catenin signaling in mesenchymal progenitors Controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Celi, 8, 739-750.

de Lau, W. B., B. Snel et H. C. Clevers (2012). The R-spondin protein family. Genome Biol, 13, 242.

de 01iveira Silva, C., S. Delbosc, C. Arais, L. Monnier, J. P. Cristol et N. Pares-Herbute (2008). Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats. Nutr Metab Cardiovasc Dis, 18, 23-30.

Deghenghi, R. (1997). The development of 'impemous peptides' as growth hormone secretagogues. Acta Paediatr Suppl, 423, 85-87.

Delaisse, J. M. (2014). The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation. Bonekey Rep, 3, 561.

Delmas, P. D., R. Eastell, P. Gamero, M. J. Seibel et J. Stepan (2000). The use of biochemical markers of bonę tumover in osteoporosis. Committee of scientific advisors of the intemational osteoporosis foundation. Osteoporos Int, 11 Suppl 6, S2-17.

Demers, A., N. McNicoll, M. Febbraio, M. Servant, S. Marleau, R. Silverstein et H. Ong (2004). Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study. Biochem 7, 382, 417-424.

Demers, A., A. Rodrigue-Way et A. Tremblay (2008). Hexarelin signaling to PPARgamma in metabolic diseases. PPAR Res, 2008, 364784.